LYELL IMMUNOPHARMA INC's ticker is LYEL and the CUSIP is 55083R104. A total of 95 filers reported holding LYELL IMMUNOPHARMA INC in Q4 2022. The put-call ratio across all filers is 0.74 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,677 | -26.0% | 20,869 | +60.0% | 0.00% | -25.0% |
| Q2 2023 | $41,477 | +34.7% | 13,043 | 0.0% | 0.00% | +33.3% |
| Q1 2023 | $30,781 | -32.0% | 13,043 | 0.0% | 0.00% | -40.0% |
| Q4 2022 | $45,259 | -46.1% | 13,043 | 0.0% | 0.01% | -54.5% |
| Q3 2022 | $84,000 | -93.4% | 13,043 | -94.9% | 0.01% | -94.1% |
| Q1 2022 | $1,280,000 | -66.3% | 253,512 | -48.4% | 0.19% | -69.9% |
| Q4 2021 | $3,803,000 | – | 491,372 | – | 0.62% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 20,162,332 | $69,963,292 | 35.72% |
| Orland Properties Ltd | 15,093,969 | $52,376,072 | 27.91% |
| Foresite Capital Management IV, LLC | 10,000,000 | $34,700,000 | 14.82% |
| MIC Capital Management UK LLP | 3,060,569 | $10,620,174 | 2.10% |
| Alphabet Inc. | 5,865,125 | $20,351,984 | 1.18% |
| HSG Holding Ltd | 3,045,997 | $10,569,610 | 1.07% |
| Artal Group S.A. | 700,000 | $2,429 | 0.14% |
| Eagle Health Investments LP | 100,000 | $347,000 | 0.08% |
| Virtus ETF Advisers LLC | 39,345 | $136,527 | 0.07% |
| BBR PARTNERS, LLC | 164,041 | $569,222 | 0.06% |